When focusing specifically on GLP-1 use among patients with an obesity diagnosis, there is an even larger disparity between states, with rates ranging from 14.8% in Alaska to just 2.3% in Arizona
However, your specific situation may require a different approach depending on your age and fertility status, underlying medical conditions like PCOS or diabetes, how long youve been on GLP-1s, how much weight youve lost, your personal fertility history, and other medications youre taking
The growth hormone signal remains clean and targeted
Whether you choose Ro's rapid model, Found's comprehensive approach, or PlexusDx's precision-wellness framework, the goal remains the same: safe, effective, personalized metabolic care
& Max, M
The early phase focuses on allowing your body to adjust while minimizing potential side effects as your system adapts to this gradual metabolic change